Healthcare Reform e-Health technologies such as remote monitoring and remote diagnosis provide a tangible opportunity to shift the balance of healthcare away from the hospitals and into the community with benefits for patients and the healthcare system as a whole. As part of the European Semester process, Country Specific Recommendations for Ireland issued in June 2014 contain recommendations on a number of issues including reform of the healthcare sector initiated under the Future Health Strategic Framework to increase cost- effectiveness. A key reform in this regard is the increased use of ehealth. eHealth implementation is identified by the Commission as one of the Societal Challenges for the upcoming decades. It covers the ICT-based interaction between patients and health-service providers, institution-to-institution data transmission, peer-to-peer communication between patients or health professionals. It also includes health information networks, electronic health records, and tele-medicine services, including personal wearable and portable communicable systems for monitoring and supporting patients. eHealth is increasingly being seen in the context of new health delivery models outside of traditional hospital computing environments, with a view of patient information extending across the full range of care settings. This will involve building relationships with both the ICT industry and academia, working in tandem with our partners in Europe and progressing the eHealth agenda in line with the EU eHealth Action Plan 2012 – 2020, to maximise the potential for innovation and improvement. A critical component of implementing this strategy is the ubiquitous availability and accessibility of Broadband infrastructure and Next Generation Access. EU/IMF commitments in this regard related to the publication of an eHealth Strategy and the publication of the Health Identifiers Bill. The eHealth Strategy was published in December 2013 and its implementation is underway. The Health Identifiers Bill was also published in December 2013 and is being progressed steadily through the Oireachtas. The Bill provides the legal basis for Individual Health Identifiers for health service users and unique identifiers for health service providers. The identifiers will be used across the health service, both public and private. Individual Health Identifiers are primarily about patient safety and ensuring that the right information is associated with the right individual at the point of care. Indi...
Healthcare Reform. At such time as regulations are issued implementing the Affordable Care Act (ACA), the City and Escondido FFA will meet and confer to review the impact of such regulations on the benefits plans then in force. If modifications to the benefits, eligibility for coverage, employer or employee contribution to the cost of insurance, or any other provisions of the benefit plans covered by this MOU will be modified or may be affected by the ACA during the term of this agreement, it is agreed that the City and Escondido FFA will reopen the contract to meet and confer and determine how such mandated changes will be implemented, and to possibly address other health plan options. EXHIBIT "A" FIRE SAFETY PERSONNEL INCREASES SALARY RANGES JANUARY 2021 Union Code Job Description Base Step 2 Step 3 Step 4 Step 5 Step 6 Step 7 FIR FF/Paramedic 5,702 5,987 6,286 6,601 6,931 7,277 7,641 FIR Fire Engineer 5,987 6,286 6,601 6,931 7,277 7,641 8,023 FIR Fire Captain 7,027 7,379 7,747 8,135 8,542 8,969 9,417 EXHIBIT "A" FIRE SAFETY PERSONNEL INCREASES SALARY RANGES JANUARY 24, 2021 - 4.0% SALARY INCREASE Union Code Job Description Base Step 2 Step 3 Step 4 Step 5 Step 6 Step 7 FIR FF/Paramedic 5,930 6,227 6,538 6,865 7,208 7,568 7,947 FIR Fire Engineer 6,227 6,538 6,865 7,208 7,568 7,947 8,344 FIR Fire Captain 7,308 7,674 8,057 8,460 8,883 9,327 9,794 EXHIBIT "A" FIRE NON-SAFETY PERSONNEL INCREASES SALARY RANGES JANUARY 2021 Union Code Job Description Base Step 2 Step 3 Step 4 Step 5 NSF Paramedic 3,883 4,077 4,281 4,495 4,719 EXHIBIT "A" FIRE NON-SAFETY PERSONNEL INCREASES SALARY RANGES JANUARY 24, 2021 - 4.0% SALARY INCREASE Union Code Job Description Base Step 2 Step 3 Step 4 Step 5 NSF Paramedic 4,038 4,240 4,452 4,674 4,908
Healthcare Reform. Customer agrees it is solely responsible for ensuring that its group health plans comply with any applicable requirements of the federal healthcare reform law (the Patient Protection and Affordable Care Act of 2010, as amended by the Healthcare and Education Reconciliation Act of 2010, together with any applicable regulations issued pursuant to those Acts) and for determining if its group health plans are grandfathered health plans for purposes of those requirements. Customer is solely responsible for determining what, if any, effect the services provided under this Agreement may have on the grandfathered status of its group health plans. BHS is not responsible for ensuring that any group health plan qualifies or continues to qualify as a grandfathered health plan.
Healthcare Reform. During the past decade, a number of attempts have been made by Congress and by the Clinton Administration to reform healthcare. The most notorious and unsuccessful was attempted in 1992 by Xxxxxxx Xxxxxx Xxxxxxx’x panel. Under this model, the U.S. government would be the single payer, funded by payroll taxes, for all healthcare. This created concern about price regulation, and the stocks of all major U.S. pharmaceutical firms declined. The attempt failed due to its complexity and the objections of special interest groups. Successfully implemented reforms include Medical Savings accounts and portable healthcare insurance. In addition, industrial organizations like AT&T and GE (which have thousands of employees covered and are a major market for the drugs) demand, and have obtained, large discounts allowing drugs to be covered by their healthcare plan. Hence there is severe price pressure on the drug industry as regulations and customers change. FDA approval of drugs. The FDA has been under pressure from Congress to speedily approve drugs for life threatening conditions like AIDS and cancer. The review time has gone down from around 12-18 months in early 1990 to about 9-12 months in 1998. The FDA also has expedited review (now about six months) for a special category called breakthrough drug12. Expedited review drugs include Xxxxxx- Xxxxxxx’x Rezulin diabetes drug. A major drug company has to have a good relationship with the FDA and understand the process to win approval for its drugs. This has created a major entry barrier for the United States, the world’s largest pharmaceutical market. Major non-U.S. drug firms either have this capability (such as Glaxo Wellcome) or have teamed up with a U.S. company (such as Japan’s Sankyo, which allied with Xxxxxx Xxxxxxx to market Rezulin in the United States).
Healthcare Reform. In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of drug product candidates, restrict or regulate post-approval activities, and affect the profitable sale of drug product candidates. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality, and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. In March 2010, the Affordable Care Act, formally known as the Patient Protection and Affordable Care Act (the “ACA”), was enacted by Congress, and signed into law by the President. It substantially changed the methods by which healthcare is financed by both the government and private insurers, and significantly impacted the United States pharmaceutical industry. The ACA, among other things: (i) increased the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extended the rebate program to individuals enrolled in Medicaid-managed care organizations; (ii) established an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription drugs and biologic agents apportioned among these entities according to their market share in some government healthcare programs; (iii) expanded the availability of lower pricing under the 340B drug pricing program by adding new entities to the program; (iv) increased the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program; (v) expanded the eligibility criteria for Medicaid programs; (vi) created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; and (vii) established a Center for Medicare & Medicaid Innovation to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drugs. Some of the provisions of the ACA have yet to be implemented, and there have been judicial and Congressional challenges to certain aspects of the ACA. While Congress has not passed com...
Healthcare Reform. The parties recognize that certain State and Federal laws, programs and regulations, including the Affordable Care Act, may impact future medical plan offerings. Effective July 2017, either party may request to reopen Section 4,A,(2) regarding medical insurance for the purpose of discussing alternative approaches and proposals to providing healthcare coverage. In addition, should State or Federal laws concerning taxation of healthcare benefits change, the parties agree to meet and discuss the impact of such change.
